10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
PLEASANTON, Calif., Jan. 19, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the…
27,353$
-0,46%
Echtzeit-Aktienkurs 10x Genomics Inc.
Bid:
Ask:
Nachrichten zur 10x Genomics Inc. Aktie
3 Medical Info Systems Stocks Braving Industry-wide Headwinds
Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to…
Human Gene Sequencing Market Report 2023: Featuring 10x Genomics, Abbott Diagnostics, Eurofins Scientific, GE Global Research & More
DUBLIN, Jan. 5, 2023 /PRNewswire/ -- The "Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology,…
10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 28, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology…
Spatial Genomics, Transcriptomics and Proteomics Solutions Market Report 2022: Featuring 10x Genomics, Lunaphore Technologies, Canopy Biosciences & More
DUBLIN, Dec. 22, 2022 /PRNewswire/ -- The "Spatial Genomics, Transcriptomics and Proteomics Solutions Market - Distribution by Type of Solution,…
10x Genomics Commercially Launches Xenium Platform for In Situ Analysis
Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif., Dec. 8, 2022…
10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery
Barcode Enabled Antigen Mapping (BEAM) screens multiple antigens against thousands of B- or T-cells to identify novel and rare antigen-specific…
Form 10-Q 10x Genomics, Inc. For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of 17.78% and 1.32%, respectively, for the quarter ended September 2022. Do…
10x Genomics GAAP EPS of -$0.37 beats by $0.11, revenue of $131.07M beats by $1.94M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Will 10x Genomics Disappoint Investors Again?
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
10x Genomics to Host Investor Day on December 8, 2022
PLEASANTON, Calif., Oct. 31, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will host an Investor Day on…
10x Genomics to Report Third Quarter Financial Results on November 2, 2022
PLEASANTON, Calif., Oct. 12, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the…